WDR6 and breast carcinoma: As shown in Figure 2M−P, The RFS, DSS, DMFS, and OS of breast cancer patients in the WDR6 high‐expression group were significantly longer than the WDR6 low‐expression group, which kept in with the survival data from the Kaplan−Meier plotter data set, and these data further suggested that WDR6 served as a potential and favorable biomarker on clinical diagnosis and therapy for breast cancer.